fda statement bpc-157 not approved fda.gov An advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8-6 votes (with BPC-157 vs. TB-500: What Patients

BPC 157 vs. TB 500: What Patients Should Know I just testified at an FDA meeting on whether seven popular peptides should be allowed in compounding. Just last month, FDA medical officers determined that none of the peptides met the agency's Peptides are all the range and you as the consumer should be informed of current peptide restrictions and potential safety concerns. We are ruled by the FDA. This is a blessing and can be a curse lol. A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring!

SKU: 70652206680 · From www.marsberger-treibhaus.de